Orsense - Non-Invasive Technologues

Please choose your location:

   
Orsense - non-invasive technologies

About Us > Board of Directors

Hadar Ron, M.D.

Dr. Ron is Managing Partner at Israel Healthcare Ventures (IHCV), a venture capital fund specializing in Life Science companies.

Warren Roiter

Israel Healthcare Ventures (IHCV), a venture capital fund specializing in Life Science companies.

Ken Sawyer

Founding Partner of Saints Capital, a leading direct secondary investor in growth companies

Michael Rosehill

Member of LFH board , a large UK private group with extensive international investment interests.  Experienced in finance and private equity.

Lisa Danzig, M.D.

Dr. Danzig is Vice President, Development and Medical Affairs at PaxVax, a specialty vaccine company in Redwood City, California. She joined PaxVax in early 2015, following an 18 year tenure in Vaccine and Diagnostics Development roles, most recently as Global Head of Medical & Scientific Affairs at Grifols (formerly Novartis Diagnostics). She has contributed to the development of meningococcal vaccines (Menjugate®, Menveo® and Bexsero®) and has worked in Siena, Italy, Cambridge, MA and Hangzhou, China.

Dr. Danzig received her medical degree from Oregon Health Sciences University and completed residency and fellowship training in Internal Medicine and Infectious Diseases in San Francisco. 

Yoav Reisman

OrSense CEO